Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?

Title
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?
Authors
Keywords
-
Journal
PHARMACOLOGICAL RESEARCH
Volume 65, Issue 4, Pages 430-436
Publisher
Elsevier BV
Online
2012-01-28
DOI
10.1016/j.phrs.2012.01.004

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started